CXCL8 and Schwartz-Jampel syndrome: NAC has been proved to have a therapeutic effect in SjS mainly by attenuating ocular symptoms but is also believed to act as an anti-inflammatory agent by blocking IL-8 and ICAM-1 expression in epithelial cells, as has been described in the field of obstructive pulmonary disease (47, 48).